Last checked at 2 Mar 2020 09:48
UK BROKER RATINGS SUMMARY: BoFA Upgrades Burberry And Rolls-Royce
UK BROKER RATINGS SUMMARY: BoFA Upgrades Burberry And Rolls-Royce
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades585
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,994.00
Bid:
2,004.00
Ask:
2,006.00
Change:
13.00 (0.66%)
Spread:
2.00 (0.10%)
Open:
1,987.00
High:
2,008.00
Low:
1,979.00
Prev. Close:
1,981.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.2 Mar 2020 09:27
UPDATE 2-London stocks rebound as investors bet on central bank stimulus
* BP, Shell lead gains as supply cut hopes boost oil prices * Miners rise; interest-rate sensitive banks, airlines decline * FTSE 100 up 1.1%, FTSE 250 falls 0.2% (Adds stock close) By Devik Jain and C Nivedita March 2 (R...
Read more27 Feb 2020 17:12
LONDON MARKET CLOSE: FTSE In Correction Territory As Virus Fears Mount
LONDON MARKET CLOSE: FTSE In Correction Territory As Virus Fears Mount
Read more27 Feb 2020 11:54
LONDON MARKET MIDDAY: Travel Stocks Bear Brunt As Virus Fears Heighten
LONDON MARKET MIDDAY: Travel Stocks Bear Brunt As Virus Fears Heighten
Read more27 Feb 2020 10:49
UK WINNERS & LOSERS SUMMARY: WPP Down 15% As 2020 Outlook Disappoints
UK WINNERS & LOSERS SUMMARY: WPP Down 15% As 2020 Outlook Disappoints
Read more27 Feb 2020 09:58
UPDATE 3-Pandemic fears pummel European stocks into correction territory
(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Travel and leisure, basic resources stocks worst hit* WPP leads losses on STOXX 600 after bleak forecast* Standard Chartered, AB InBev latest victims of virus damage* Hikma P...
Read more27 Feb 2020 09:23
UPDATE 2-UK shares briefly slip into correction as coronavirus wreaks havoc
* FTSE 100 down 3.5%, FTSE 250 slides 4.1%* Both indexes briefly in correction* StanChart slips after warning on virus hit* WPP slides as Q4 disappoints* Hikma outshines on bright forecast (Writes through)By Sagarika Jaisinghani, Devik Jain and Shas...
Read more27 Feb 2020 08:09
CORRECTED-UPDATE 1-Hikma sees 2020 sales growth after profit beats view on newer drugs
(Corrects to say U.S. sales rose 5%, not 61%, and removes reference to double-digit growth across segments in paragraph four)* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* ...
Read more27 Feb 2020 08:09
UPDATE 1-Hikma sees 2020 sales growth after profit beats view on newer drugs
* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* Currently does not see material impact from coronavirus outbreak (Adds details on outlook, background)Feb 27 (Reuters) - Hikm...
Read more27 Feb 2020 07:29
Hikma posts decent results as it signs 'Ryaltris' deal with Glenmark
(Sharecast News) - Hikma Pharmaceuticals reported a 6% improvement in group core revenue in its preliminary results on Thursday, to $2.2bn (£1.7bn).
Read more20 Feb 2020 16:05
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more20 Feb 2020 13:40
Thursday broker round-up
(Sharecast News) - Travis Perkins: Citigroup upgrades to buy with a target price of 1,900p.
Read more17 Feb 2020 13:05
Monday broker round-up
(Sharecast News) - Hikma Pharmatheuticals: Citigroup downgrades to neutral with a target price of 1,980p.
Read more23 Jan 2020 17:13
UPDATE 1-Blues health insurers put up $55 million to take on generic drug makers
(Adds detail on new venture)By Caroline HumerNEW YORK, Jan 23 (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have litt...
Read more13 Jan 2020 10:34
UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance
UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance
Read more